Breaking News
March 24, 2018 - New findings highlight need to reconsider cervical cancer screening guidelines
March 24, 2018 - Smartwatch App Might Help Detect A-Fib
March 24, 2018 - TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis
March 24, 2018 - Kids with severe brain injuries may develop ADHD: study
March 24, 2018 - Researchers explore ways to help older adults taper off and stop using sedatives
March 24, 2018 - Back pain being mismanaged globally
March 24, 2018 - Fingerprint test accurately and noninvasively detects heroin, cocaine users
March 24, 2018 - Leading experts to promote cardiovascular health at EuroPrevent 2018
March 24, 2018 - A Role for Rituximab in Lupus?
March 24, 2018 - New osteoarthritis genes discovered
March 24, 2018 - Maternal intake of DHA supplement linked to higher fat-free body mass in children
March 24, 2018 - Royal College of Pathologists‘ bulletin provides summary of Tissue Handling Workshop
March 24, 2018 - Maternal alcohol use early in pregnancy may be risk factor for infant abdominal malformation
March 24, 2018 - Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection
March 24, 2018 - Accelerated WBI Should be the Norm for Most Breast Cancers
March 24, 2018 - Experts seek to standardize treatments for childhood rheumatic diseases
March 24, 2018 - Foil-based measuring chip rapidly detects Legionella
March 24, 2018 - Bariatric surgery linked to positive outcomes in very obese adolescents with type 2 diabetes
March 24, 2018 - Are there risks from secondhand marijuana smoke? Early science says yes.
March 24, 2018 - New University of Bath project seeks to make injections safer
March 24, 2018 - Higher-dose RT does not improve survival but reduces recurrence risk for prostate cancer patients
March 24, 2018 - Researchers examine link between knee pain and depression in older adults
March 24, 2018 - FDA Alert: BD Vacutainer Blood Collection Tubes by Becton, Dickinson and Company (BD): Class I Recall
March 24, 2018 - Daytime Sleepiness Linked to Amyloid Accumulation Without Dementia
March 24, 2018 - Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy
March 24, 2018 - Praising people with autism shows promise for producing more exercise
March 24, 2018 - Using harmless red or infrared light to diagnose breast cancer
March 24, 2018 - Clash over abortion hobbles a health bill. Again. Here’s how.
March 23, 2018 - Virtual nature environment could be new way to recover from stress
March 23, 2018 - New study identifies key cellular mechanisms behind vascular aging in mice
March 23, 2018 - Nightmares Common Among U.S. Troops, But Seldom Reported
March 23, 2018 - Another Record Low for Tuberculosis in U.S.
March 23, 2018 - Changes in the eye connected to a decline in memory
March 23, 2018 - Radiologist creates dramatic teaching tool using power of VR
March 23, 2018 - Grilled meat could be raising the risk of hypertension finds study
March 23, 2018 - Mutations found in bassoon gene may help explain cause of rare brain disorder
March 23, 2018 - Childhood Brain Injuries May be Linked to ADHD Years Later
March 23, 2018 - Why treating addiction with medication should be carefully considered
March 23, 2018 - Researchers make key discovery about cellular pathway linked to myriad of diseases
March 23, 2018 - Researchers uncover cause of rare childhood neurodegenerative disease
March 23, 2018 - Measles infection in early childhood could contribute to later COPD
March 23, 2018 - Opioid painkiller is top prescription in 11 states
March 23, 2018 - Sienna Biopharmaceuticals Announces First Patient Dosed In Proof-of-Concept Trial of Topical By Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
March 23, 2018 - In Teen Girls, Neural Patterns May Drive Emotional Resilience
March 23, 2018 - Gene-based test for urine detects, monitors bladder cancer
March 23, 2018 - BD to introduce new digital solution for IV chemotherapy administration process at EAHP 2018
March 23, 2018 - New computational method helps to identify tumor cell mutations with greater accuracy
March 23, 2018 - Researchers identify potential obesity treatment in freezing hunger-signaling nerve
March 23, 2018 - Wales participates in the 100,000 Genomes Project
March 23, 2018 - 24-Hr Paging Cuts ED Visits for Kids with Endocrine Issues
March 23, 2018 - The brain learns completely differently than we’ve assumed since the 20th century
March 23, 2018 - Less nutritious diet mainly contributes to Type 2 diabetes among U.S.-based South Asians
March 23, 2018 - Stony Brook Medicine expert provides tips for healthy diet to decrease cancer risk
March 23, 2018 - New findings could have revolutionary impact on quality of life of older people
March 23, 2018 - Restoring enzyme may help reverse effects of vascular aging, study shows
March 23, 2018 - Protein profiling reveals new prostate cancer mechanisms
March 23, 2018 - Depression may be linked to increased risk of atrial fibrillation
March 23, 2018 - FDA Takes Aim at Flavored Tobacco
March 23, 2018 - SMART Strategy Lowers Asthma Exacerbation Risk
March 23, 2018 - Cold open water plunge provides instant pain relief
March 23, 2018 - Portable and wearable technology supports future of military medical devices
March 23, 2018 - Patients with vascular malformations have poor health-related quality of life
March 23, 2018 - Researchers develop unique technology to overcome global antibiotic resistance crisis
March 23, 2018 - New DOD grant to support testing of promising therapy for triple-negative breast cancer
March 23, 2018 - Novel vaccine technologies can help better prepare for future infectious disease threats
March 23, 2018 - OncoBreak: Colonoscopy TV; Coverage for Genomic Testing; Care for Caregivers
March 23, 2018 - For some surgeries, nerve blocks mean better outcomes, fewer opioids
March 23, 2018 - Maternal obesity and androgen excess induce sex-specific anxiety in offspring, study suggests
March 23, 2018 - The tale of Theranos and the mysterious fire alarm
March 23, 2018 - USC researchers create algorithm to optimize substance abuse intervention groups
March 23, 2018 - Impulsivity may be associated with greater weight loss during treatment in obese children
March 23, 2018 - CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
March 23, 2018 - Senate Panel Addresses Native Americans’ Opioid Troubles
March 23, 2018 - Brain connections in schizophrenia
March 23, 2018 - Mental health assessment in health checks can help detect psychologically vulnerable people
March 23, 2018 - New test for urothelial cancers offers less invasive, more accurate detection
March 23, 2018 - Groundbreaking 100,000 Genomes Project achieves important milestone to transform NHS care
March 23, 2018 - Mice getting a new lease of life with anti-aging pills
March 23, 2018 - Obesity kills taste buds and dulls taste sensation finds study
March 23, 2018 - Medical students get less formal education in radiation oncology, study finds
Stop-Smoking Drug May Also Help with Excessive Boozing

Stop-Smoking Drug May Also Help with Excessive Boozing

image_pdfDownload PDFimage_print

Action Points

  • Treatment with the nicotine-dependence drug varenicline (Chantix), along with medical management, was associated with reductions in heavy drinking among male, but not female, smokers with comorbid alcohol-use disorder.
  • Note that the finding of a smoking-cessation benefit with varenicline in participants who reported little motivation to quit raises important questions about the current practice of offering treatment only to smokers who express a desire to give up cigarettes.

Treatment with the nicotine-dependence drug varenicline (Chantix), along with medical management, was associated with modest reductions in heavy drinking among male smokers with comorbid alcohol-use disorder in a small randomized trial.

Men — but not women — in the placebo-controlled study showed a small benefit from varenicline in heavy drinking measures, Stephanie O’Malley, PhD, of Yale School of Medicine in New Haven, Connecticut, and colleagues reported in JAMA Psychiatry.

The 131 participants were all active smokers. Although they were not seeking and were not provided smoking-cessation counseling during the study, 13% in the varenicline group were not smoking at the end of the trial, while none of those randomized to the placebo arm of the study had quit smoking.

O’Malley said this finding has implications for the future use of varenicline and other smoking-cessation therapies, which are typically offered in the primary care setting exclusively to patients who say they are ready to give up tobacco products.

“This suggests that first-line medications designed to help people quit smoking should be offered to patients, even if they are not ready to quit,” she told MedPage Today.

“Individuals who reduce their drinking have greater success quitting smoking, and individuals who quit smoking are more likely to maintain long-term alcohol abstinence,” she said. “Further, treatment is more cost-effective when both behaviors are addressed. Treating one behavior without addressing the co-morbid condition reduces the effectiveness of the intervention.”

O’Malley said the current study is not the first to evaluate varenicline as a treatment for alcohol abuse, but most prior trials enrolled both smokers and nonsmokers. The current study also included a more intensive counseling approach than most previous studies.

The phase II, placebo-controlled trial was conducted at outpatient clinics affiliated with Columbia University and Yale School of Medicine, and participants were recruited primarily through print, radio, and social media advertising, and through outreach to healthcare professionals.

Eligible participants met alcohol-dependence criteria and reported heavy drinking (five or more drinks for men and four or more drinks for women) two or more times per week and smoking two or more times per week.

The 131 participants were randomized to treatment with either varenicline (1 mg twice daily for 16 weeks) or placebo, stratified by sex and site. Data analysis was conducted from February 5, 2016, to September 29, 2017.

Medical management emphasized medication adherence for 4 weeks followed by support for changing drinking.

The main outcomes measured were the percentage of heavy drinking days during weeks 9 to 16, no heavy drinking days during weeks 9 to 16, and prolonged smoking abstinence during weeks 13 to 16.

About 30% of study participants were women. Mean age was 42 and about half identified themselves as black.

Thirteen of 45 men (29%) had no heavy drinking days while taking varenicline, compared with three of 47 men (6%) taking placebo. Just one of the 19 women (5%) taking varenicline had no heavy drinking days, compared with five of 20 (25%) taking placebo.

O’Malley said the failure to show an advantage for active treatment in women could be due to the relatively small number of females recruited for the trial, as well as gender differences in alcohol and nicotine dependence. Women in the study were also more likely than men to have their dosage of varenicline reduced.

“Each of these factors may have contributed to the findings, and for these reasons we cannot draw firm conclusions about the effect of varenicline in women,” she said.

In an accompanying editorial, A. Eden Evins, MD, and John F. Kelly, PhD, of Harvard Medical School and Massachusetts General Hospital Center for Addiction Medicine in Boston, wrote that while more study of the observed gender difference is needed, “the findings are consistent with the lack of evidence that medication has anti-craving or anti-relapse effects on alcohol use by alcohol-addicted women and reports that men and women respond differently to commonly sought interventions or mechanisms such as Alcoholics Anonymous.”

Nevertheless, the editorial writers also found that it may be premature to conclude that varenicline is not effective for reducing heavy drinking in women. They suggested the trial may have been underpowered for more definitive conclusions, in part because of exclusion criteria that ended up rejecting more than two-thirds of those screened. “Replication with larger samples is warranted in this intriguing line of investigation,” they wrote.

Evins and Kelly noted that the finding of a smoking-cessation benefit with varenicline in participants who reported little motivation to quit raises important questions about the current practice of offering treatment only to smokers who express a desire to give up cigarettes.

“As treatment professionals, we do not reserve pharmacotherapy for hypertension or type 2 diabetes for people who are ready to make diet and exercise changes. That analogy is not perfect, but effective pharmacotherapeutic smoking cessation aids have been extensively shown to be well tolerated and can reduce craving, withdrawal symptoms, and reward from smoking to such an extent that they can prompt smoking-cessation attempts in smokers who are not able to commit to a cessation attempt prior to treatment.”

Funding for the study was provided by the National Institutes of Health and the State of Connecticut Department of Mental Health and Addiction Services.

O’Malley reported financial relationships with Pfizer, Alkermes, Amygdala, Arkeo, Cerecor, Mitsubishi Tanabe, Opiant; being a member of the American Society of Clinical Psychopharmacology Alcohol Clinical Trials Initiative, which is supported by Abbott, Amygdala, Ethypharm, Lilly, Lundbeck, Otsuka, Pfizer, Arbor Pharmaceuticals, and Indivior; a co-investigator on studies receiving donated medications from AstraZeneca and Novartis; and a scientific panel member for Hazelden Foundation.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner


last updated

Tagged with:

About author

Related Articles